PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-52

  1. 353 Posts.
    lightbulb Created with Sketch. 399
    Not shooting the messenger, but surely 2022/06/20220112 is not the right one? Also says enrolling?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.